XML 21 R8.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Registered shares
Additional paid-in capital
Treasury shares
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive loss
Beginning of the period (in shares) at Mar. 31, 2019     173,106   7,244      
Beginning of the period at Mar. 31, 2019 $ 1,176,339   $ 30,148 $ 56,655 $ (169,802) $ 1,365,036   $ (105,698)
Increase (Decrease) in Shareholders' Equity                
Cumulative effect of adoption of new accounting standard 434,761         449,723   (14,962)
Purchases of registered shares (in shares)         1,251      
Purchases of registered shares (50,437)       $ (50,437)      
Sale of shares upon exercise of options and purchase rights (in shares)         (1,101)      
Sale of shares upon exercise of stock options and purchase rights 22,241     5,582 $ 16,659      
Issuance of shares upon vesting of restricted stock units (in shares)         (1,184)      
Issuance of shares upon vesting of restricted stock units (24,280)     (41,964) $ 17,684      
Share-based compensation 54,824     54,824        
Cash dividends (124,180)         (124,180)    
End of the period (in shares) at Mar. 31, 2020     173,106   6,210      
End of the period balance at Mar. 31, 2020 $ 1,489,268 $ (553) $ 30,148 75,097 $ (185,896) 1,690,579 $ (553) (120,660)
Increase (Decrease) in Shareholders' Equity                
Accounting Standards Update [Extensible List] Accounting Standards Update 2016-13 [Member]              
Cumulative effect of adoption of new accounting standard $ 959,002         947,257   11,745
Purchases of registered shares (in shares)         1,845      
Purchases of registered shares (164,952)       $ (164,952)      
Sale of shares upon exercise of options and purchase rights (in shares)         (1,786)      
Sale of shares upon exercise of stock options and purchase rights 43,810     3,130 $ 40,680      
Issuance of shares upon vesting of restricted stock units (in shares)         (1,080)      
Issuance of shares upon vesting of restricted stock units (32,082)     (53,093) $ 21,011      
Issuance of shares for contingent consideration (in shares)         (390)      
Issuance of shares from contingent consideration 28,463     18,847 $ 9,616      
Share-based compensation 85,538     85,538        
Cash dividends (146,705)         (146,705)    
End of the period (in shares) at Mar. 31, 2021     173,106   4,799      
End of the period balance at Mar. 31, 2021 2,261,789   $ 30,148 129,519 $ (279,541) 2,490,578   (108,915)
Increase (Decrease) in Shareholders' Equity                
Cumulative effect of adoption of new accounting standard 649,305         644,513   4,792
Purchases of registered shares (in shares)         4,607      
Purchases of registered shares (412,022)       $ (412,022)      
Sale of shares upon exercise of options and purchase rights (in shares)         (410)      
Sale of shares upon exercise of stock options and purchase rights 29,649     12,971 $ 16,678      
Issuance of shares upon vesting of restricted stock units (in shares)         (1,137)      
Issuance of shares upon vesting of restricted stock units (64,156)     (105,972) $ 41,816      
Issuance of shares for contingent consideration (in shares)         (4)      
Issuance of shares from contingent consideration 292     116 $ 176      
Share-based compensation 93,291     93,291        
Cash dividends (159,410)         (159,410)    
End of the period (in shares) at Mar. 31, 2022     173,106   7,855      
End of the period balance at Mar. 31, 2022 $ 2,398,738   $ 30,148 $ 129,925 $ (632,893) $ 2,975,681   $ (104,123)